ATE425183T1 - P53-bindendes polypeptid - Google Patents

P53-bindendes polypeptid

Info

Publication number
ATE425183T1
ATE425183T1 AT03756559T AT03756559T ATE425183T1 AT E425183 T1 ATE425183 T1 AT E425183T1 AT 03756559 T AT03756559 T AT 03756559T AT 03756559 T AT03756559 T AT 03756559T AT E425183 T1 ATE425183 T1 AT E425183T1
Authority
AT
Austria
Prior art keywords
binding polypeptide
polypeptide
activity
inhibits
interfere
Prior art date
Application number
AT03756559T
Other languages
English (en)
Inventor
Xin Lu
Patricia Kuwabara
David Selwood
Original Assignee
Ludwig Inst For Cancer Res Ltd
Genome Res Ltd
Ucl Cruciform Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0223193A external-priority patent/GB0223193D0/en
Priority claimed from GB0306261A external-priority patent/GB0306261D0/en
Application filed by Ludwig Inst For Cancer Res Ltd, Genome Res Ltd, Ucl Cruciform Ltd filed Critical Ludwig Inst For Cancer Res Ltd
Application granted granted Critical
Publication of ATE425183T1 publication Critical patent/ATE425183T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03756559T 2002-10-07 2003-10-03 P53-bindendes polypeptid ATE425183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0223193A GB0223193D0 (en) 2002-10-07 2002-10-07 Polypeptide
GB0306261A GB0306261D0 (en) 2003-03-19 2003-03-19 Polypeptide

Publications (1)

Publication Number Publication Date
ATE425183T1 true ATE425183T1 (de) 2009-03-15

Family

ID=32071253

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03756559T ATE425183T1 (de) 2002-10-07 2003-10-03 P53-bindendes polypeptid
AT08153666T ATE537186T1 (de) 2002-10-07 2003-10-03 P53-bindendes polypeptid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08153666T ATE537186T1 (de) 2002-10-07 2003-10-03 P53-bindendes polypeptid

Country Status (8)

Country Link
US (2) US20060100143A1 (de)
EP (2) EP1947113B1 (de)
JP (1) JP2006517787A (de)
AT (2) ATE425183T1 (de)
AU (1) AU2003299132A1 (de)
CA (1) CA2487206A1 (de)
DE (1) DE60326623D1 (de)
WO (1) WO2004031229A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0514538D0 (en) * 2005-07-14 2005-08-24 Ludwig Inst Cancer Res Variant polypeptide and screening assay
DK2118123T3 (en) * 2007-01-31 2016-01-25 Dana Farber Cancer Inst Inc Stabilized p53 peptides and uses thereof
US8592377B2 (en) 2007-03-28 2013-11-26 President And Fellows Of Harvard College Stitched polypeptides
GB0716322D0 (en) * 2007-08-21 2007-10-03 Cancer Rec Tech Ltd Crystal structure
ES2711526T3 (es) 2010-08-13 2019-05-06 Aileron Therapeutics Inc Macrociclos peptidomiméticos
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
BR112014020103A2 (pt) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. macrociclos peptidomiméticos
EP2819688A4 (de) 2012-02-15 2015-10-28 Aileron Therapeutics Inc Triazol- und thioethervernetzte peptidomimetische makrozyklen
US9880171B2 (en) 2012-03-02 2018-01-30 Ludwig Institute For Cancer Research Ltd. iASPP phosphorylation and metastatic potential
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
US9873718B2 (en) 2013-05-08 2018-01-23 The Regents Of The University Of California Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
AU2015320545C1 (en) 2014-09-24 2020-05-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
EP3197478A4 (de) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetische makrozyklen und verwendungen davon
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2017044633A1 (en) 2015-09-10 2017-03-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of mcl-1
US20180284114A1 (en) * 2015-10-02 2018-10-04 Arizona Board Of Regents On Behalf Of Arizona State University Methods for processing biopolymeric arrays
US11091522B2 (en) 2018-07-23 2021-08-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397834B1 (de) 1988-10-28 2000-02-02 Genentech, Inc. Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
EP0368684B2 (de) 1988-11-11 2004-09-29 Medical Research Council Klonierung von Immunglobulin sequenzen aus den variabelen Domänen.
US6291158B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
JP2000516472A (ja) 1996-08-16 2000-12-12 メディカル リサーチ カウンシル 組織特異的遺伝子発現を与える自己複製型エピソーム性発現ベクター
KR100272659B1 (ko) 1997-06-28 2000-12-01 김영환 반도체 소자의 금속배선 선폭 측정방법
CA2319089A1 (en) 1998-04-09 1999-10-21 Genset S.A. 5' ests and encoded human proteins
WO2000032628A1 (en) * 1998-12-03 2000-06-08 Ono Pharmaceutical Co., Ltd. ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
JP2002538810A (ja) 1999-03-12 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
AU5286999A (en) * 1999-07-23 2001-02-13 Glaxo Group Limited Combination of an anti-ep-cam antibody with a chemotherapeutic agent
US20040053262A1 (en) 2000-08-04 2004-03-18 Xin Lu Supressor gene

Also Published As

Publication number Publication date
US20060100143A1 (en) 2006-05-11
ATE537186T1 (de) 2011-12-15
EP1947113B1 (de) 2011-12-14
CA2487206A1 (en) 2004-04-15
EP1947113A1 (de) 2008-07-23
US7745571B2 (en) 2010-06-29
WO2004031229A3 (en) 2004-09-23
AU2003299132A1 (en) 2004-04-23
HK1083220A1 (en) 2006-06-30
WO2004031229A2 (en) 2004-04-15
EP1558638B1 (de) 2009-03-11
US20080260756A1 (en) 2008-10-23
DE60326623D1 (de) 2009-04-23
JP2006517787A (ja) 2006-08-03
EP1558638A2 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
ATE425183T1 (de) P53-bindendes polypeptid
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
DK1353941T3 (da) Modificerede zinkfingerbindingsproteiner
MX2007001345A (es) Regiones variantes fc.
ATE485303T1 (de) Isoformen von gehirn-natriuretischem peptid
DK1534335T3 (da) FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf
PT1171465E (pt) Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
BRPI0418286A (pt) proteìnas de fusão de il-7
NO20063624L (no) FC region varianter
ATE542920T1 (de) Modifiziertes menschliches wachstumshormon
DE60304031D1 (de) Atmungsaktive und elastische verbundmaterialien und methoden
CY1112875T1 (el) Sfrp και πεπτιδικα μοτιβα που διαντιδρουν με την sfrp και μεθοδοι χρησης τους
DE60332711D1 (de) Neue insektizide proteine von bazillus thuringiensis
AU8497701A (en) Claudin polypeptides
DE50206480D1 (de) Antimikrobiell wirkendes peptid
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
WO2004017992A3 (en) Ptk7 protein involvement in carcinoma
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60120220D1 (de) Screening-verfahren auf basis der siah-numb-wechselwirkung
ATE485831T1 (de) Behandlung von neurodegeneration
EA200500624A1 (ru) Промотор для il-18bp, его получение и применение
WO2003095484A3 (en) Polypeptides increasing p53 expression
ATE487734T1 (de) Polypeptide, abgeleitet von der amyloid vorläuferprotein (app), und ihre verwendungen
WO2006003427A8 (en) A protein involved in carcinoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties